Marijuana use among those at risk for cardiovascular events
Noninvasive, medical management for non—ST-elevation acute coronary syndromes
Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy)
Clinical and research issues regarding chronic advanced coronary artery disease
Clinical and research issues regarding chronic advanced coronary artery disease Part II
Rationale and design of the Home Automatic External Defibrillator Trial (HAT)
Post—myocardial infarction β-blocker therapy
An exploratory prospective study of marijuana use and mortality following acute myocardial infarction
Missed opportunities for reperfusion therapy for ST-segment elevation myocardial infarction
Weight Change after Myocardial Infarction—the Enhancing Recovery in Coronary Heart Disease patients (ENRICHD) Experience
Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction
Xa inhibition and coagulation activity—the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals
Hemoglobin levels and coronary artery disease
Prevention of radiocontrast medium—induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial—a randomized controlled study
Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome
Association of premature ventricular complexes with central aortic pressure indices and pulse wave velocity
Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Remission of left ventricular systolic dysfunction and of heart failure symptoms after cardiac resynchronization therapy
Poor functional status based on the New York Heart Association classification exposes the coronary patient to an elevated risk of ischemic stroke
Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications
Clinical implications of midventricular obstruction and intravenous propranolol use in transient left ventricular apical ballooning (Tako-tsubo cardiomyopathy)
Associations between neurohormonal and inflammatory activation and heart failure in children
The relative value of metabolic syndrome and cardiovascular risk score estimates in premature acute coronary syndromes
Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery
The volume-outcome relationship of percutaneous coronary intervention
Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease
Clinical utility of automated assessment of left ventricular ejection fraction using artificial intelligence—assisted border detection
Potential unintended financial consequences of pay-for-performance on the quality of care for minority patients
Hospital readmissions in children with congenital heart disease
Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients
Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients
Letter to the Editor
Letter to the Editor
Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with cardiorenal anemia syndrome
Letter to the Editor